title: FK 506 and rapamycin: molecular probes of T-lymphocyte activation.
authors.affiliation: Division of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA 02115.
authors.forename: B E
authors.initials: BE
authors.lastname: Bierer
authors.forename: Y J
authors.initials: YJ
authors.lastname: Jin
authors.forename: D A
authors.initials: DA
authors.lastname: Fruman
authors.forename: V
authors.initials: V
authors.lastname: Calvo
authors.forename: S J
authors.initials: SJ
authors.lastname: Burakoff
mesh_terms: D000818:Animals; D002352:Carrier Proteins / Q000235:genetics / Q000502:physiology; D006801:Humans; D007166:Immunosuppressive Agents / Q000494:pharmacology*; D008213:Lymphocyte Activation / Q000187:drug effects*; D008954:Models, Biological; D011090:Polyenes / Q000494:pharmacology*; D015398:Signal Transduction / Q000187:drug effects*; D020123:Sirolimus; D013601:T-Lymphocytes / Q000187:drug effects / Q000276:immunology*; D016559:Tacrolimus / Q000378:metabolism / Q000494:pharmacology*; D022021:Tacrolimus Binding Proteins
chemical_list: D002352:Carrier Proteins; D007166:Immunosuppressive Agents; D011090:Polyenes; D022021:Tacrolimus Binding Proteins; D020123:Sirolimus; D016559:Tacrolimus